Discover 521 paid clinical trials in Calgary, . Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Calgary runs one of the busiest research programs in western Canada, with hundreds of studies recruiting at any given time.The Arthur J.E. Child Comprehensive Cancer Centre opened in Calgary in October 2024, making cancer research the city's fastest-growing trial area. Roughly a third of Calgary's recruiting studies are in oncology, and the rest cluster around heart failure, kidney disease, and metabolic conditions, much of it run through the University of Calgary. The city is also unusual for the volume of paediatric research at Alberta Children's Hospital, so families often find studies here that are not available elsewhere in the province.
Filter
2
Filter results
Results: 521
CAlgary SAlt for POTS
for
Postural Orthostatic Tachycardia Syndrome
Location: Calgary
Sponsor: University of Calgary
Sex: All
Age: 18 - 60
Code: NCT05924646
Recruiting
POTS Adrenergic Ab (CIHR Aims #1&2)
for
Postural Tachycardia Syndrome
Location: Calgary
Sponsor: University of Calgary
Sex: All
Age: 18 - 60
Code: NCT02673996
Recruiting
Pharmacogenomics of Stimulant Treatment Response
for
Attention-Deficit/ Hyperactivity Disorder (ADHD)
Location: Calgary
Sponsor: University of Calgary
Sex: All
Age: 6 - 24
Code: NCT06221358
Recruiting
Hormone Therapy and Angiotensin-Dependent Arterial and Renal Vasoconstriction in Humans
for
Hormone Therapy
Location: Calgary
Sponsor: University of Calgary
Sex: All
Age: 18 - 70+
Code: NCT05442463
Recruiting
ACCESS HD: Comparing Catheters to Fistulas in Elderly Patients Starting Hemodialysis
for
End-stage Kidney Failure
Location: Calgary, Toronto, Ottawa
Sponsor: University of Calgary
Sex: All
Age: 55+
Code: NCT02675569
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Psilocybin-Assisted Psychotherapy for Alcohol Use Disorder
for
Alcohol Use Disorder, Alcoholism
Location: Calgary
Sponsor: University of Calgary
Sex: All
Age: 22 - 65
Code: NCT05995769
Phase 2, Recruiting
A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations